<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-045120</identifier>
<setSpec>1130-5665</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">Obesity: pathogenic issues, associated cardiovascular illness, and therapeutic approach</dc:title>
<dc:description xml:lang="en">Obesity is the most frequent metabolic disturbance thataffects human beings. This disease appears due to the excessof fatty tissue which is produced because of progressive accumulationof fat on its reservoirs, as a response to misbalanceon caloric homeostasis where food intake exceedsenergetic needs. Obesity affects around 33% of adult population,and near 30 million dollars is inverted each year onspecial foods, and programs to reduce body weight; however,treatments applied have been unsuccessful, and almost90% of people who loose weight, gain the lost weight again.This article shows a review about obesity where we mainlyemphasis in concept and epidemiology, pathophysiology, itsrelation with cardiovascular diseases, and current treatment</dc:description>
<dc:creator>Cepero Franco, S</dc:creator>
<dc:creator>Llanes Pelegrín, R. J</dc:creator>
<dc:creator>Rodríguez Oliva, N</dc:creator>
<dc:creator>Moreno Martínez, F. L</dc:creator>
<dc:creator>López Bernal, O. J</dc:creator>
<dc:language>es</dc:language>
<dc:description xml:lang="es">La obesidad es la alteración metabólica más frecuente delos seres humanos. Esta enfermedad aparece debido al excesode tejido adiposo que se produce por la acumulación progresivade grasa en sus reservorios debido a un desequilibrio dela homeostasis calórica donde la ingestión excede el gastoenergético. Afecta aproximadamente al 33% de los adultos ycada año se invierten en alimentos especiales y programas parareducir el peso corporal cerca de 30 millones de dólares; sinembargo, los tratamientos empleados han sido ineficaces y casiel 90% de las personas que bajan de peso, aumentan nuevamenteel peso perdido. En este artículo presentamos una revisiónsobre la obesidad, haciendo especial énfasis en ladefinición y su epidemiología, su patogenia, la relación conenfermedades cardiovasculares y el tratamiento actualizado</dc:description>
<dc:source>MAPFRE med;16(3): 209-222, jul. 2005. tab</dc:source>
<dc:identifier>ibc-045120</dc:identifier>
<dc:title xml:lang="es">Obesidad: aspectos patogénicos, alteraciones cardiovasculares asociadas y estrategias terapéuticas</dc:title>
<dc:subject>^d29611</dc:subject>
<dc:subject>^d9951^s22067</dc:subject>
<dc:subject>^d2181^s22031</dc:subject>
<dc:subject>^d2359^s22080</dc:subject>
<dc:subject>^d28612</dc:subject>
<dc:subject>^d4813^s22031</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d9951^s22080</dc:subject>
<dc:subject>^d4071^s22074</dc:subject>
<dc:subject>^d23631</dc:subject>
<dc:subject>^d1073^s22073</dc:subject>
<dc:type>article</dc:type>
<dc:date>200507</dc:date>
</metadata>
</record>
</ibecs-document>
